Showing results (41-50 of 318) with videos related to
Sort By:
Pageof 32
Drug Metabolism and Pharmacokinetics|June 8, 2012
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokineticsTomoyuki Mizuno, Masahide Fukudo, Tomohiro Terada, et al.American Journal of Physiology. Renal Physiology|May 30, 2008
Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylationMasayo Aoki, Tomohiro Terada, Moto Kajiwara, et al.International Journal of Clinical Oncology|March 27, 2010
Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case studyKeiko Shinsako, Tomoyuki Mizuno, Tomohiro Terada, et al.Organic Letters|February 14, 2006
Unequivocal synthesis of (Z)-alkene and (E)-fluoroalkene dipeptide isosteres to probe structural requirements of the peptide transporter PEPT1Ayumu Niida, Kenji Tomita, Makiko Mizumoto, et al.American Journal of Physiology. Renal Physiology|September 15, 2007
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1Moto Kajiwara, Tomohiro Terada, Jun-ichi Asaka, et al.Journal of Human Genetics|April 17, 2008
Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidneyKen Ogasawara, Tomohiro Terada, Hideyuki Motohashi, et al.Pharmacology & Therapeutics|June 9, 2006
An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patientsSatohiro Masuda, Ken-ichi InuiBiochemical Pharmacology|December 15, 2010
Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agentsAtsushi Yonezawa, Ken-Ichi InuiMolecular Aspects of Medicine|March 20, 2013
Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-KHideyuki Motohashi, Ken-ichi InuiBritish Journal of Pharmacology|April 5, 2011
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomicsAtsushi Yonezawa, Ken-ichi InuiPageof 32